Tzu-Chieh Ho

Dr. Tzu-Chieh Ho

Pediatrics, Indiana University School of Medicine, Indianapolis, Indiana, USA
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 September 2016 in Blood
Verified
Journal Article
Open access
PDF file
Tzu-Chieh HoTzu-Chieh Ho
Tzu-Chieh Ho
MLMark LaMere
Mark LaMere
BSBrett M. Stevens
Brett M. Stevens
JAJohn M. Ashton
John M. Ashton
JMJason R. Myers
Jason R. Myers
MBMichael W. Becker
Michael W. Becker
Key Points: Using AML as a model, we investigated the effect of treatment and disease evolution on functionally defined cancer stem cell populations. We demonstrate large-scale changes in LSC frequency and phenotype after relapse, best described using high-dimensional space analyses.

7 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
HHHanyao Huang
Hanyao Huang
WPWeiyi Pan
Weiyi Pan
YWYifan Wang
Yifan Wang
HKHye Sung Kim
Hye Sung Kim
DSDan Shao
Dan Shao
KLKam W Leong
Kam W Leong
Periodontitis is a common type of inflammatory bone loss and a risk factor for systemic diseases. The pathogenesis of periodontitis involves inflammatory dysregulation, which represents a target for new therapeutic strategies to treat periodontitis. After establishing the correlation of cell-free DNA (cfDNA) level with periodontitis in patient samples, we test the hypothesis that the cfDNA-scavenging approach will benefit periodontitis treatment. We create a nanoparticulate cfDNA scavenger specific for periodontitis by coating selenium-doped hydroxyapatite nanoparticles (SeHANs) with cationic polyamidoamine dendrimers (PAMAM-G3), namely G3@SeHANs, and compare the activities of G3@SeHANs with those of soluble PAMAM-G3 polymer. Both G3@SeHANs and PAMAM-G3 inhibit periodontitis-related proinflammation in vitro by scavenging cfDNA and alleviate inflammatory bone loss in a mouse model of ligature-induced periodontitis. G3@SeHANs also regulate the mononuclear phagocyte system in a periodontitis environment, promoting the M2 over the M1 macrophage phenotype. G3@SeHANs show greater therapeutic effects than PAMAM-G3 in reducing proinflammation and alveolar bone loss in vivo. Our findings demonstrate the importance of cfDNA in periodontitis and the potential for using hydroxyapatite-based nanoparticulate cfDNA scavengers to ameliorate periodontitis.

1 March 2017 in Cell Stem Cell
Verified
Journal Article
Closed access
AKAndriana G. Kotini
Andriana G. Kotini
CCChan-Jung Chang
Chan-Jung Chang
ACArthur Chow
Arthur Chow
HYHan Yuan
Han Yuan
Tzu-Chieh HoTzu-Chieh Ho
Tzu-Chieh Ho
EPEirini P. Papapetrou
Eirini P. Papapetrou

21 May 2021 in Science Advances
Verified
Journal Article
Open access
PDF file
Tzu-Chieh HoTzu-Chieh Ho
Tzu-Chieh Ho
HKHye Sung Kim
Hye Sung Kim
YCYumei Chen
Yumei Chen
Yamin LiYamin Li
Yamin Li
MLMark W. LaMere
Mark W. LaMere
KLKam W Leong
Kam W Leong
Leukemia stem cells (LSCs) sustain the disease and contribute to relapse in acute myeloid leukemia (AML). Therapies that ablate LSCs may increase the chance of eliminating this cancer in patients. To this end, we used a bioreducible lipidoid-encapsulated Cas9/single guide RNA (sgRNA) ribonucleoprotein [lipidoid nanoparticle (LNP)–Cas9 RNP] to target the critical gene interleukin-1 receptor accessory protein (IL1RAP) in human LSCs. To enhance LSC targeting, we loaded LNP-Cas9 RNP and the chemokine CXCL12α onto mesenchymal stem cell membrane–coated nanofibril (MSCM-NF) scaffolds mimicking the bone marrow microenvironment. In vitro, CXCL12α release induced migration of LSCs to the scaffolds, and LNP-Cas9 RNP induced efficient gene editing. IL1RAP knockout reduced LSC colony-forming capacity and leukemic burden. Scaffold-based delivery increased the retention time of LNP-Cas9 in the bone marrow cavity. Overall, sustained local delivery of Cas9/IL1RAP sgRNA via CXCL12α-loaded LNP/MSCM-NF scaffolds provides an effective strategy for attenuating LSC growth to improve AML therapy.

18 May 2018 in Advanced Science
Verified
Journal Article
Open access
PDF file
YLYeh‐Hsing Lao
Yeh‐Hsing Lao
Mingqiang LiMingqiang Li
Mingqiang Li
MGMadeleine A. Gao
Madeleine A. Gao
DSDan Shao
Dan Shao
CCChun‐Wei Chi
Chun‐Wei Chi
KLKam W Leong
Kam W Leong
CRISPR/Cas9 technology enables targeted gene editing; yet, the efficiency and specificity remain unsatisfactory, particularly for the nonvirally delivered, plasmid‐based CRISPR/Cas9 system. To tackle this, a self‐assembled micelle is developed and evaluated for human papillomavirus (HPV) E7 oncogene disruption. The optimized micelle enables effective delivery of Cas9 plasmid with a transient transgene expression profile, benefiting the specificity of Cas9 recognition. Furthermore, the feasibility of using the micelle is explored for another nucleic acid‐guided nuclease system, Natronobacterium gregoryi Argonaute (NgAgo). Both systems are tested in vitro and in vivo to evaluate their therapeutic potential. Cas9‐mediated E7 knockout leads to significant inhibition of HPV‐induced cancerous activity both in vitro and in vivo, while NgAgo does not show significant E7 inhibition on the xenograft mouse model. Collectively, this micelle represents an efficient delivery system for nonviral gene editing, adding to the armamentarium of gene editing tools to advance safe and effective precision medicine‐based therapeutics.

1 April 2019 in Cell Reports
Verified
Journal Article
Open access
BABiniam Adane
Biniam Adane
HYHaobin Ye
Haobin Ye
NKNabilah Khan
Nabilah Khan
SPShanshan Pei
Shanshan Pei
MMMohammad Minhajuddin
Mohammad Minhajuddin
CJCraig T. Jordan
Craig T. Jordan
The NADPH-dependent oxidase NOX2 is an important effector of immune cell function, and its activity has been linked to oncogenic signaling. Here, we describe a role for NOX2 in leukemia-initiating stem cell populations (LSCs). In a murine model of leukemia, suppression of NOX2 impaired core metabolism, attenuated disease development, and depleted functionally defined LSCs. Transcriptional analysis of purified LSCs revealed that deficiency of NOX2 collapses the self-renewal program and activates inflammatory and myeloid-differentiation-associated programs. Downstream of NOX2, we identified the forkhead transcription factor FOXC1 as a mediator of the phenotype. Notably, suppression of NOX2 or FOXC1 led to marked differentiation of leukemic blasts. In xenotransplantation models of primary human myeloid leukemia, suppression of either NOX2 or FOXC1 significantly attenuated disease development. Collectively, these findings position NOX2 as a critical regulator of malignant hematopoiesis and highlight the clinical potential of inhibiting NOX2 as a means to target LSCs.